Literature DB >> 22739634

Understanding the cost-effectiveness of bivalirudin.

Amit P Amin, Elizabeth A Magnuson.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22739634     DOI： 10.1136/heartjnl-2012-301649

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  2 in total

Review 1.  Clinical and economic studies of eptifibatide in coronary stenting.

Authors:  Tilak Pasala; Prasongchai Sattayaprasert; Pradeep K Bhat; Ganesh Athappan; Sanjay Gandhi
Journal:  Ther Clin Risk Manag       Date:  2014-08-02       Impact factor: 2.423

2.  Bivalirudin Versus Heparin During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.

Authors:  Hiten Patel; Rana Garris; Suchit Bhutani; Priyank Shah; Upamanyu Rampal; Rahul Vasudev; Gabriel Melki; Bader Abu Ghalyoun; Hartaj Virk; Mahesh Bikkina; Fayez Shamoon
Journal:  Cardiol Res       Date:  2019-10-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.